Procedure for Stability Testing According to ICH Q1A(R2) Guidelines

1) Purpose

The purpose of this SOP is to define the procedures for implementing the ICH Q1A(R2) guidelines for the stability testing of active pharmaceutical ingredients (APIs) and drug products. This ensures that products maintain their quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in stability testing of APIs and drug products, including quality control, product development, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for selecting suitable API and excipient combinations.
Stability Study Team: Responsible for conducting stability studies according to ICH guidelines.
Quality Assurance Team: Responsible for reviewing data for compliance with ICH requirements.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol according to ICH Q1A(R2) guidelines.

4.1.2 Include test parameters such as assay, impurities, physical properties, and container closure integrity.

4.2

“Shielding Medications from Light Degradation: Unveiling Cutting-Edge Photostability Strategies Elevating Pharmaceutical Stabilization to New Heights!”

4.2.1 Prepare samples of APIs and drug products in their final packaging.

4.2.2 Store samples under specified conditions (e.g., long-term, intermediate, and accelerated) as per ICH guidelines.

4.3 Conducting Stability Tests

4.3.1 Perform stability tests at defined intervals (e.g., 0, 3, 6, 12, 24 months).

4.3.2 Document all data and ensure compliance with